89
Views
0
CrossRef citations to date
0
Altmetric
Review

Prevention of Herpes Zoster Pain

&
Pages 63-69 | Published online: 21 Dec 2011

References

  • Hope-Simpson RE . The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med.58 , 9–20 (1965).
  • Ragozzino MW , MeltonLJ, KurlandLT, ChuCP, PerryHO. Population-based study of herpes zoster and its sequelae. Medicine61 , 310–316 (1982).
  • Toyama N , Shiraki K; The Society of the Miyazaki Prefecture Dermatologists. Epidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J. Med. Virol.81 , 2053–2058 (2009).
  • Donahue JG , ChooPW, MansonJ, PlattR. The incidence of herpes zoster. Arch. Intern. Med.155 , 1605–1609 (1995).
  • Drolet M , BrissonM, LevinMJ et al. A prospective study of herpes zoster severity of illness. Clin. J. Pain 26 , 656–666 (2010).
  • Hempenstall K , NurmikkoTJ, JohnsonRW, A‘HernRP, RiceASC. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med.2(7) , E164 (2005).
  • Oxman MN , LevinMJ, JohnsonGR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352(22) , 2271–2346 (2005).
  • Rubben A , BaronJM, Grussendorf-ConenEI. Routine detection of herpes simplex virus by polymerase chain reaction reveals that initial herpes zoster is frequently misdiagnosed as herpes simplex. Br. J. Dermatol.137 , 259–261 (1997).
  • Jung BF , JohnsonRW, GriffinDRJ, DworkinRH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology62 , 1545–1551 (2004).
  • Drolet M , BrissonM, SchmaderK et al. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J. Pain 11 , 1211–1221 (2010).
  • Johnson RW , BouhassiraD, KassianosG, LeplègeA, SchmaderKE, WeinkeT. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med.8 , 37 (2010).
  • Kilgore PE , Kruszon-MoranD, SewardJF et al. Varicella in Americans from NHANES 111: implications for control through routine immunization. J. Med. Virol. 70(Suppl. 1) , S111–S118 (2003).
  • Brisson M , EdmundsWJ, GayNJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J. Med. Virol.70(Suppl. 1) , S31–S37 (2003).
  • Dworkin RH , JohnsonRW, BreuerJ, GnannJW, LevinMJ. Recommendations for the management of herpes zoster. Clin. Infect. Dis.44(Suppl. 1) , S1–S26 (2007).
  • Dworkin RH , BoonRJ, GriffinDR, PhungD. Postherpetic neuralgia: impact of famciclovir, age, rash severity and acute pain in herpes zoster patients. J. Infect. Dis.178(Suppl. 1) , S76–S80 (1998).
  • Li Q , ChenN, YangJ et al. Antiviral treatment for preventing postherpetic neuralgia (review). Cochrane Database Syst. Rev. 2 , 1–43 (2009).
  • Eaglstein WH , KatzR, BrownJA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA211 , 1681–1683 (1970).
  • Esmann V , GeilJP, KroonS et al. Prednisolone does not prevent postherpetic neuralgia. Lancet 2 , 126–129 (1987).
  • Wood MJ , JohnsonRW, McKendrickMW, TaylorJ, MandalBK, CrooksJ. A randomized trial of acyclovir for 7 or 21 days with and without prednisolone for treatment of acute herpes zoster. N. Engl. J. Med.330 , 896–900 (1994).
  • Whitley RJ , WeissH, GnannJW et al. Acyclovir with and without prednisone for the treatment of herpes zoster. Ann. Intern. Med. 125 , 376–383 (1996).
  • Higa K , HoriK, HarasawaI, HirataK, DanK. High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: comparison with effects of stellate ganglion block. Reg. Anesth. Pain Med.23 , 25–29 (1998).
  • Ji G , NiuJ, ShiY, HouL, LuY, XiongL. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth. Analg.109 , 1651–1655 (2009).
  • Pasqualucci A , PasqualucciV, GallaF et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol. Scand. 44 , 910–918 (2000).
  • Kumar V , KroneK, MathieuA. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg. Anesth. Pain Med.29 , 454–461 (2004).
  • Lapolla W , DigiorgioC, HaitzK et al. Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. Arch. Dermatol. 147 , 901–908 (2011).
  • Krcevski Skvarc N , KamenikM. Effects of pregabalin on acute herpetic pain and postherpetic neuralgia incidence. Wien. Klin. Wochenschr.122(Suppl. 2) , 49–53 (2010).
  • Dworkin RH , BarbanoRL, TyringSK et al. A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain 142 , 209–217 (2009).
  • Bowsher D . The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J. Pain Symptom Manage.13(6) , 327–331 (1997).
  • Paek E , JohnsonR. Public awareness and knowledge of herpes zoster: results of a global survey. Gerontology56(1) , 20–31 (2010).
  • Johnson RW . Patient awareness of herpes zoster: the Global Herpes Zoster Survey – a preliminary report. Herpes13(Suppl. 1) , 40A–41A (2006).
  • van Hoek AJ , MelegaroA, ZagheniE, EdmundsWJ, GayN. Modelling the impact of a combined varicella and vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine29 , 2411–2420 (2011).
  • Emery EC , YoungGT, BerrocosoEM, ChenL, McNaughtonPA. HCN2 ion channels play a central role in inflammatory and neuropathic pain. Science333(6048) , 1462–1466 (2011).
  • Schmader K , GnannJW Jr, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J. Infect. Dis.197(Suppl. 2) , S207–S215 (2008).
  • Gnann JW Jr, Whitley RJ. Clinical practice: herpes zoster. N. Engl. J. Med.347 , 340–346 (2002).
  • Gnann JW Jr. Antiviral therapy for herpes zoster. Herpes13(Suppl. 1) , 16A–20A (2006).
  • Christo PJ , HobelmannG, MaineDN. Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management. Drugs Aging24 , 1–19 (2007).
  • Dworkin RH . Post-herpetic neuralgia. Herpes13(Suppl. 1) , 21A–27A (2006).
  • Tyring S , BarbarashRA, NahlikJE et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann. Intern. Med. 123 , 89–96 (1995).
  • Beutner KR . Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res.28 , 281–290 (1995).
  • Oxman MN , Levin MJ; Shingles Prevention Study Group. Vaccination against herpes zoster and postherpetic neuralgia.J. Infect. Dis.197(Suppl. 2) , S228–S236 (2008).
  • Schmader K . Herpes zoster in older adults. Clin. Infect. Dis.32 , 1481–1486 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.